SHL Telemedicine Ltd. (SWX:SHLTN)
Switzerland · Delayed Price · Currency is CHF 1.060
-0.010 (-0.93%)
Sep 11, 2026, 5:30 PM CET
SHL Telemedicine Employees
SHL Telemedicine had 526 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
526
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
95.39K CHF
Profits / Employee
-22.99K CHF
Market Cap
39.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 526 | 0 | - |
| Dec 31, 2024 | 526 | -57 | -9.78% |
| Dec 31, 2023 | 583 | 181 | 45.02% |
| Dec 31, 2022 | 402 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,267 |
| Lonza Group AG | 20,141 |
| Galderma Group AG | 7,676 |
| Ascom Holding AG | 1,376 |
| Molecular Partners AG | 134 |
| BioVersys AG | 38 |
| Newron Pharmaceuticals | 27 |
SHL Telemedicine News
- 9 months ago - Value Base Ltd. Acquires Significant Stake in SHL Telemedicine Ltd. - GuruFocus
- 1 year ago - DocGo and SHL Telemedicine Partner to Revolutionize Patient Access to Cardiovascular Care - Business Wire
- 2 years ago - SHL Telemedicine to Appoint David Arnon as CEO of SHL Telemedicine - Business Wire
- 2 years ago - SHL Telemedicine Confirms Discussions Regarding a Possible Investment in its Israeli Activity - Business Wire
- 2 years ago - SHL Telemedicine Expands Offering in Israel With Groundbreaking At-home Biomarker Blood Test - Business Wire
- 2 years ago - SHL Telemedicine Announces Official Launch of SmartHeart® D2C Membership in the US Following Successful Soft Launch - Business Wire
- 2 years ago - SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones - Business Wire
- 2 years ago - Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine's SmartHeart® in Post-ACS Patient Care - Business Wire